Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial.

Yuichiro FujiedaTetsuya HoritaNaoki NishimotoKazuhide TanimuraYoshiharu AmasakiHideki KasaharaShin FurukawaTsuyoshi TakedaShinji FukayaKazuo MatsuiAkito TsutsumiAkira FurusakiAkira SagawaKou KatayamaKaoru TakeuchiKazuaki KatsumataTakashi KuritaPeter ShaneMasaru KatoKenji OkuShinsuke YasudaMasahiko TakahataNorimasa IwasakiTatsuya Atsumi

Published in: Modern rheumatology (2020)

Risedronate was effective in increasing L-BMD and was well tolerated in patients with GIO complicated with RA.

Keyphrases

double blind
placebo controlled
rheumatoid arthritis
clinical trial
phase iii
study protocol
disease activity
phase ii
high glucose
open label
ankylosing spondylitis
diabetic rats
bone mineral density
systemic lupus erythematosus
interstitial lung disease
oxidative stress
cross sectional